Behind the Mystery Explores Rare Disease, Transthyretin-Mediated Amyloidosis / ATTR Tomorrow on Lifetime

Award-winning morning show The Balancing Act® will be featuring a special segment on the rare and genetic disease of Transthyretin-Mediated Amyloidosis / ATTR as part of the “Behind the Mystery: Rare and Genetic Diseases” programming. The episode airs tomorrow, September 30th, 2015 on Lifetime TV.

About The Balancing Act®

Entering its 7th season, The Balancing Act continues to empower women in all aspects of their lives. The mission at The Balancing Act is simple – to help today’s modern woman balance it all by bringing them positive solutions to enrich and empower them. Entertaining, educational and trusted by women, viewers can tune in to America’s premier morning show The Balancing Act on weekday mornings Monday through Friday at 7:30 am (ET/PT) on Lifetime television. For additional information or to view a segment visit: www.thebalancingact.com
For more information regarding O2 Media, Branded Entertainment, Product Placement and TV Brand Integration go to:http://o2mediainc.com/Pages/187/Branded-Entertainment

Join the Conversation on Facebook, on Twitter and on YouTube.